Trials / Completed
CompletedNCT00335712
Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Ono Pharma USA Inc · Industry
- Sex
- All
- Age
- 45 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-5129 |
Timeline
- Start date
- 2006-06-01
- First posted
- 2006-06-12
- Last updated
- 2012-06-13
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00335712. Inclusion in this directory is not an endorsement.